This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by D’Alfonso, R. Articles by Sesti, G. Search for Related Content PubMed PubMed Citation Articles by D’Alfonso, R. Articles by Sesti, G.

Polymorphisms of the Insulin Receptor Subtrate-2 in Patients with Type 2 Diabetes

Laboratory of Molecular Medicine, Department of Internal Medicine (R.D., M.A.M., S.F., O.P., L.M.M., D.L., S.G., M.F., R.L.), and Department of Neuroscience (R.S.), University of Rome-Tor Vergata, 00133 Rome, Italy; Institute of Internal Medicine, Endocrine and Metabolic Disease (L.F.), University of Catania, Garibaldi Hospital, 95123 Catania, Italy; Unit of Endocrinology (V.T.), Scientific Institute Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy; Department of Clinical Science (V.T.), University of Rome-"La Sapienza", 00185 Rome, Italy; and Dipartimento di Medicina Sperimentale e Clinica (G.S.), Università di Catanzaro-Magna Græcia, 88100 Catanzaro, Italy

Address all correspondence and requests for reprints to: Giorgio Sesti, M.D., Dipartimento di Medicina Sperimentale e Clinica, Università Magna Græcia di Catanzaro, Via Tommaso Campanella, 115 88100 Catanzaro, Italy. E-mail:sesti{at}unicz.it.

We investigated the significance of Gly1057Asp and Leu647Val insulin receptor substrate (IRS)-2 polymorphisms in two Italian cohorts comprising 186 glucose-tolerant subjects and 240 subjects with type 2 diabetes from the Lazio region (i.e. representative of central Italy), and 123 glucose-tolerant subjects from the Sicily region (i.e. representative of south Italy). The allelic frequency of Gly1057Asp variant did not differ between diabetics (32.9%) and nondiabetic subjects, whatever their ethnicity was (35.8% and 33.7% from Lazio and Sicily, respectively). As compared with Gly/Gly subjects within each group, Asp/Asp individuals showed no differences in quantitative traits, including fasting insulin and C-peptide, and several indices of insulin sensitivity and secretion. Only one of the diabetic patients was heterozygous for the Leu647Val variant, and none of the control subjects carried this variant. This patient had three children who were also heterozygous for this variant. They were glucose tolerant, and their insulin sensitivity and insulin secretion indices were within the range of age-matched controls. We also analyzed IRS-2 function in fibroblasts from carriers of Gly1057Asp or Leu647Val variant. No defects in IRS-2 expression, insulin-stimulated phosphorylation, or binding to the p85 subunit of phosphatidylinositol 3-kinase were observed. These results strongly argue against a major role of IRS-2 polymorphisms in the pathogenesis of type 2 diabetes.

This work was supported in part by grants from European Community (QLG1-CT-1999-00674, to G.S.) and Progetto di Ricerca Finalizzata from Ministero della Sanità (G.S.).

Abbreviations: BMI, Body mass index; FGIR, fasting glucose to insulin ratio; HDL, high-density lipoprotein; HOMA, homeostasis model assessment; IRS, insulin receptor substrate; PI, phosphatidylinositol; QUICKI, quantitative insulin sensitivity check index.

This article has been cited by other articles:

				K. Wagner, K. Hemminki, E. Grzybowska, R. Klaes, D. Butkiewicz, J. Pamula, W. Pekala, H. Zientek, D. Mielzynska, E. Siwinska, et al. The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer Carcinogenesis, December 1, 2004; 25(12): 2473 - 2478. [Abstract] [Full Text] [PDF]